These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2046150)

  • 1. [Hepatic functional evaluation using the galactose tolerance test in patients with obstructive jaundice].
    Kaiho T; Miyazaki M; Udagawa I; Koshikawa H; Iinuma K; Ito H; Kimura F; Matsumoto J; Isono T; Suzuki H
    Nihon Shokakibyo Gakkai Zasshi; 1991 Mar; 88(3):689-97. PubMed ID: 2046150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced hepatic functional reserve in cirrhosis and obstructive jaundice with special reference to histological morphometric analysis and galactose elimination capacity.
    Kaiho T; Miyazaki M; Ito H; Ambiru S; Shimizu H; Togawa A; Ohtsuka M; Shiobara M; Shimizu Y; Sasada K; Yoshioka S; Yoshidome H; Nakajima N
    Eur Surg Res; 1996; 28(5):333-40. PubMed ID: 8880122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of percutaneous transhepatic biliary drainage in the correction of the metabolic capacity of the jaundiced liver by hippurate-synthesizing test.
    Kamiyama Y; Tokunaga Y; Aoyama H; Ukikusa M; Ozawa K
    Surg Gynecol Obstet; 1993 Jul; 177(1):72-6. PubMed ID: 8322155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperalimentation of jaundiced patients on percutaneous transhepatic biliary drainage.
    Foschi D; Cavagna G; Callioni F; Morandi E; Rovati V
    Br J Surg; 1986 Sep; 73(9):716-9. PubMed ID: 3092894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice.
    Chijiiwa K; Watanabe M; Nakano K; Noshiro H; Tanaka M
    Am J Surg; 2000 Feb; 179(2):161-6. PubMed ID: 10773154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of portal blood flow after percutaneous transhepatic biliary drainage in patients with obstructive jaundice.
    Kanda H; Nimura Y; Yasui A; Nakano S; Kumada S; Shionoya S
    Surg Today; 1997; 27(2):120-3. PubMed ID: 9017987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors.
    Lee JW; Han JK; Kim TK; Choi BI; Park SH; Ko YH; Yoon CJ; Yeon KM
    Cardiovasc Intervent Radiol; 2002; 25(3):176-9. PubMed ID: 12058212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation of hepatic protein synthesis and hepatic functional mass in obstructive jaundiced rats].
    Kanno Y; Miyazaki M; Udagawa I; Koshikawa H; Ito H; Teramoto O; Okui K
    Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):160-6. PubMed ID: 2038290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transhepatic biliary drainage for the treatment of obstructive jaundice caused by metastases from nonbiliary and nonpancreatic cancers.
    Iwasaki M; Furuse J; Yoshino M; Konishi M; Kawano N; Kinoshita T; Ryu M
    Jpn J Clin Oncol; 1996 Dec; 26(6):465-8. PubMed ID: 9001353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent implantation through rendezvous technique of PTBD and ERCP: the treatment of obstructive jaundice.
    Liu YD; Wang ZQ; Wang XD; Yang YS; Linghu EQ; Wang WF; Li W; Cai FC
    J Dig Dis; 2007 Nov; 8(4):198-202. PubMed ID: 17970876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic utility of serum neopterin in obstructive jaundice secondary to malignant lesions treated by percutaneous transhepatic biliary drainage.
    Yilmaz B; Parildar Z; Bozkaya H; Barutcuoglu B; Cinar C; Basol G; Parildar M; Ozmen D
    J Vasc Interv Radiol; 2013 Jun; 24(6):865-72. PubMed ID: 23707094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of percutaneous transhepatic biliary drainage at different Couinaud's hepatic entry segments for treating obstructive jaundice.
    Hsu YC; Lee HY; Chang CM; Lin CY; Liu YS; Huang HS
    Front Surg; 2023; 10():1039106. PubMed ID: 36761028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine elimination test as a guideline for selecting patients for transhepatic biliary drainage.
    Ramesh VS; Kochhar R; Garg SK; Wig JD; Gupta NM
    J Gastroenterol Hepatol; 1990; 5(3):219-22. PubMed ID: 2103402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of percutaneous transhepatic biliary drainage in patients with obstructive jaundice caused by local recurrence of gastric cancer.
    Makino T; Fujitani K; Tsujinaka T; Hirao M; Kashiwazaki M; Nakamori S; Ikenaga M; Mishima H; Masuda N; Sawamura T
    Hepatogastroenterology; 2008; 55(81):54-7. PubMed ID: 18507078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EUS-guided versus percutaneous biliary access in patients with obstructive jaundice due to gastric cancer.
    Ogura T; Okuda A; Miyano A; Imanishi M; Nishioka N; Yamada M; Yamda T; Kamiyama R; Masuda D; Higuchi K
    Dig Liver Dis; 2019 Feb; 51(2):247-252. PubMed ID: 30327252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative biliary drainage in obstructive jaundice.
    Kawarada Y; Higashiguchi T; Yokoi H; Vaidya P; Mizumoto R
    Hepatogastroenterology; 1995; 42(4):300-7. PubMed ID: 8586359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative hepatic functional risk assessed with technetium-99m diethylenetriamine pentaacetic acid-galactosyl human serum albumin liver scintigraphy in patients undergoing pancreaticoduodenectomy complicated by obstructive jaundice.
    Nakano H; Kumada K; Takekuma Y; Hasebe S; Yoshizawa Y; Yamaguchi M; Jaeck D
    Int J Pancreatol; 1999 Feb; 25(1):3-9. PubMed ID: 10211415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous transhepatic biliary drainage in the management of obstructive jaundice.
    Baijal SS; Dhiman RK; Gupta S; Sharma BC; Roy S; Agarwal DK; Choudhuri G; Saraswat VA; Naik SR
    Trop Gastroenterol; 1997; 18(4):167-71. PubMed ID: 9612100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum endothelin-1 and hepatocyte growth factor levels in patients with obstructive jaundice.
    Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Tsukamoto T; Tanaka H; Kubo S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 1999; 46(27):1599-602. PubMed ID: 10430302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten years single center experience in percutaneous transhepatic decompression of biliary tree in patients with malignant obstructive jaundice.
    Garcarek J; Kurcz J; Guziński M; Janczak D; Sasiadek M
    Adv Clin Exp Med; 2012; 21(5):621-32. PubMed ID: 23356199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.